MARKET

AMED

AMED

Amedisys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

171.13
+2.11
+1.25%
After Hours: 171.13 0 0.00% 18:05 09/17 EDT
OPEN
169.88
PREV CLOSE
169.02
HIGH
172.69
LOW
169.52
VOLUME
680.09K
TURNOVER
--
52 WEEK HIGH
325.12
52 WEEK LOW
166.01
MARKET CAP
5.58B
P/E (TTM)
22.96
1D
5D
1M
3M
1Y
5Y
Fuller & Thaler Behavioral Small-mid Core Equity Buys Pool Corp, Science Applications ...
GuruFocus News · 2d ago
Fuller & Thaler Behavioral Small Cap Equity Buys Gray Television Inc, Deckers Outdoor Corp, ...
GuruFocus News · 2d ago
EHC or AMED: Which Is the Better Value Stock Right Now?
Zacks.com · 5d ago
Where Amedisys Stands With Analysts
Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following analyst ratings:
Benzinga · 09/10 17:34
Cowen & Co. Initiates Coverage On Amedisys with Market Perform Rating, Announces Price Target of $195
Cowen & Co. analyst Gary Taylor initiates coverage on Amedisys (NASDAQ:AMED) with a Market Perform rating and announces Price Target of $195.
Benzinga · 09/10 09:26
--Cowen Initiates Amedisys With Market Perform Rating, $195 Price Target
MT Newswires · 09/09 16:31
Returns On Capital Are A Standout For Amedisys (NASDAQ:AMED)
What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Simply Wall St. · 09/08 11:03
Insider Sell: Amedisys
MT Newswires · 09/07 09:58
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMED. Analyze the recent business situations of Amedisys through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMED stock price target is 240.92 with a high estimate of 265.00 and a low estimate of 195.00.
EPS
Institutional Holdings
Institutions: 522
Institutional Holdings: 32.75M
% Owned: 100.35%
Shares Outstanding: 32.63M
TypeInstitutionsShares
Increased
128
2.15M
New
45
399.76K
Decreased
136
1.48M
Sold Out
55
454.77K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.60%
Healthcare Providers & Services
+0.93%
Key Executives
Chairman/Chief Executive Officer/Director
Paul Kusserow
President/Chief Operating Officer
Christopher Gerard
Chief Financial Officer/Executive Vice President
Scott Ginn
Chief Human Resource Officer
Sharon Brunecz
Chief Information Officer
Michael North
Chief Compliance Officer
Denise Bohnert
Other
David Kemmerly
Lead Director/Independent Director
Richard Lechleiter
Independent Director
Vickie Capps
Independent Director
Molly Coye
Independent Director
Julie Klapstein
Independent Director
Teresa Kline
Independent Director
Bruce Perkins
Independent Director
Jeffrey Rideout
Independent Director
Ivanetta Samuels
No Data
About AMED
Amedisys, Inc. is a healthcare services company. The Company's segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. The Company owns and operates approximately 524 centers in 39 states and the District of Columbia. The Company's Home Health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The Hospice segment provides support for those who are dealing with a terminal illness, such as heart disease, pulmonary disease, Alzheimer's and Human Immunodeficiency Virus (HIV)/Acquired Immuno Deficiency Syndrome (AIDS). The Personal care segment provides patients with assistance with the essential activities of daily living.

Webull offers kinds of Amedisys Inc stock information, including NASDAQ:AMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMED stock methods without spending real money on the virtual paper trading platform.